Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells

Autor: Ruvolo, Peter P., Ruvolo, Vivian R., Benton, Christopher B., AlRawi, Ahmed, Burks, Jared K., Schober, Wendy, Rolke, James, Tidmarsh, George, Hail, Numsen, Jr, Eric Davis, R., Andreeff, Michael
Zdroj: In BBA - Molecular Cell Research April 2016 1863(4):562-571
Databáze: ScienceDirect
Externí odkaz: